A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy

Phase 2 Unknown 180 enrolled Sun Yat-sen University

RandomizedParallel-groupOpen-labelTreatment

Summary

This prospective, randomized, controlled, multicenter clinical trial will evaluate Opportunity, Validity and Security of Steroids Plus Cyclosporin therapy for patients of Idiopathic Membranous Nephropathy.

Timeline

Start: 2014-06
Primary completion: 2016-12
Completion: 2016-12

Publications

von Groote TC, Williams G, Au EH, Chen Y, Mathew AT, Hodson EM, Tunnicliffe DJ. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome. Cochrane Database Syst Rev. 2021 Nov 15;11(11):CD004293. doi: 10.1002/14651858.CD004293.pub4.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cyclosporine	Peptide	3.5 mg/kg	Oral
Subject	Cyclosporine	Peptide	5 mg/kg	Oral
Subject	Methylprednisolone	Other / unclassified	0.4 mg/kg	Oral

A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy

Summary

Timeline

Publications

Drugs

Indications